CETUXIMAB IN COMBINATION WITH IRINOTECAN/5-FLUOROURACIL/FOLINIC ACID (FOLFIRI) IN THE INITIAL TREATMENT OF METASTATIC COLORECTAL CANCER: A MULTICENTRE TWO-PART PHASE I/II STUDY

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

Abstract Background This study was designed to investigate the efficacy and safety of the epidermal growth factor receptor (EGFR) inhibitor cetuximab combined with irinotecan, folinic acid (FA) and two different doses of infusional 5-fluorouracil (5-FU) in the first-line Abrasive treatment of EGFR-detectable metastatic colorectal cancer.Methods The

read more

Comparative efficacy of essential oil nanoemulsions and bioproducts as alternative strategies against root-knot nematode, and its impact on the growth and yield of Capsicum annuum L.

In a study to compare the effectiveness of some essential oil nanoemulsion and bioproducts as an alternative to chemical nematicide in control of root-knot nematode, Meloidogyne incognita parasitizing on chili pepper, Capsicum annuum L.plants, in parallel with the plant growth and yield under two varying conditions; in vitro, greenhouse and plastic

read more



Surgical Site Infections with MRSA in young Patients

Introduction: Surgical site infections (SSIs) pose a global health concern.While various pathogenic microorganisms can cause SSIs, a predominant causative agent is Staphylococcus aureus, particularly its methicillin-resistant strain (MRSA).MRSA, known for its resistance to multiple antibiotics, significantly complicates treatment options, leading t

read more